Pharmaceutical Trading Platform Yaoshibang Applies for Hong Kong IPO

May 26, 2022 0 Comments

Yaoshibang, a Chinese pharmaceutical distribution platform, submitted an application on Tuesday for a public listing to the Hong Kong Stock Exchange (HKEx), with Goldman Sachs and CICC named as co-sponsors.

Leave a Reply

Your email address will not be published.